|
適應症:(1)移植前:提供捐贈者選擇參考,檢測受贈者preexisting
(移植前)Donor
specific antibody (DSA)。
(2)移植後:監測受贈者移植後產生捐贈者DSA情形,以判定器官發生rejection原因,建議執行時機如下:(A)Positive
HLA antibody screen (B)Pre-transplant sensitization (C)Antibody
mediated allograft rejection (D)Pre-transplant desensitization。
臨床意義:(1)Donor
specific antibody (DSA)常見於產生移植後排斥反應之患者,且與移植失敗有顯著之相關。
(2)本檢驗MFI
cut-off值引用之參考文獻為
(A)MFI cutoff of 1000:Clin
Kidney J 6: 283–286, 2013 (B)MFI cutoff of 2000:Transplantation
87: 563-569, 2009 |